(Q36354769)

13 August 2017

1 reference

title

Fibronectin as target for tumor therapy (English)

1 reference

13 August 2017

3

Dario Neri

1 reference

13 August 2017

Manuela Kaspar

1

1 reference

PubMed ID

16381025

13 August 2017

Luciano Zardi

series ordinal

2

1 reference

PubMed ID

16381025

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

International Journal of Cancer

13 August 2017

1 reference

13 August 2017

118

1 reference

13 August 2017

6

1 reference

13 August 2017

1331-1339

1 reference

The multiple roles of tumour stroma

13 August 2017

1 reference

New insights into the role of extracellular matrix during tumor onset and progression.

21 January 2018

1 reference

Fibronectin and its receptors

21 January 2018

1 reference

Alternative splicing of fibronectin: Three variants, three functions

21 January 2018

1 reference

Three different fibronectin mRNAs arise by alternative splicing within the coding region

21 January 2018

1 reference

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

21 January 2018

1 reference

21 January 2018

Fibronectin at a glance

1 reference

Role of angiogenesis in tumor growth and metastasis

21 January 2018

1 reference

3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon

21 January 2018

1 reference

Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy

21 January 2018

1 reference

Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells

21 January 2018

1 reference

Modulation of cell-adhesive activity of fibronectin by the alternatively spliced EDA segment

21 January 2018

1 reference

Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.

21 January 2018

1 reference

NMR structure of the human oncofoetal fibronectin ED-B domain, a specific marker for angiogenesis

21 January 2018

1 reference

Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis

21 January 2018

1 reference

Extracellular matrix assembly

21 January 2018

1 reference

Superfibronectin is a functionally distinct form of fibronectin

21 January 2018

1 reference

A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature

21 January 2018

1 reference

Anginex, a designed peptide that inhibits angiogenesis

21 January 2018

1 reference

Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247.

21 January 2018

1 reference

Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice

21 January 2018

1 reference

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer

21 January 2018

1 reference

Tumour vascular targeting

21 January 2018

1 reference

Improving the efficacy of antibody-based cancer therapies

21 January 2018

1 reference

New approaches to antibody therapy

21 January 2018

1 reference

Making antibodies by phage display technology

21 January 2018

1 reference

Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform

21 January 2018

1 reference

Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel.

21 January 2018

1 reference

Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening

21 January 2018

1 reference

Infrared photodetection for the in vivo localisation of phage-derived antibodies directed against angiogenic markers.

21 January 2018

1 reference

Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin

21 January 2018

1 reference

A real-time in vitro assay for studying functional characteristics of target-specific ultrasound contrast agents

21 January 2018

1 reference

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

21 January 2018

1 reference

Engineering a thermostable human prolyl endopeptidase for antibody-directed enzyme prodrug therapy

21 January 2018

1 reference

Selective targeted delivery of TNFalpha to tumor blood vessels.

21 January 2018

1 reference

ED-B fibronectin as a target for antibody-based cancer treatments

21 January 2018

1 reference

Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature.

21 January 2018

1 reference

Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells.

21 January 2018

1 reference

Design, construction, and characterization of a large synthetic human antibody phage display library

21 January 2018

1 reference

An antibody-calmodulin fusion protein reveals a functional dependence between macromolecular isoelectric point and tumor targeting performance.

21 January 2018

1 reference

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

21 January 2018

1 reference

Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

21 January 2018

1 reference

Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin

21 January 2018

1 reference

Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix

21 January 2018

1 reference

Engineered vascular-targeting antibody-interferon-γ fusion protein for cancer therapy

21 January 2018

1 reference

Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins

21 January 2018

1 reference

Quantitation of the Tumor-Targeting Properties of Antibody Fragments Conjugated to Cell-Permeating HIV-1 TAT Peptides

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.21677

1 reference

13 August 2017

1 reference

PubMed ID

16381025